MiR-133a, Directly Targeted USP39, Suppresses Cell Proliferation and Predicts Prognosis of Gastric Cancer

Overview

Journal Oncol Lett

Specialty Oncology

Date 2018 May 29

PMID 29805563

Citations 9

Authors

Xiang Dong

Hailong Su

Feng Jiang

Haiyan Li

Guangwen Shi

Lijuan Fan

Affiliations

Soon will be listed here.

Abstract

Gastric cancer has high incidence and mortality, and the mortality ranks second only to lung cancer. Downregulation of miR-133a has been observed in certain types of tumors, and it is involved in gastric cancer. The aim of the present study was to explore the molecular mechanisms of miR-133a and ubiquitin-specific protease 39 (USP39) in gastric cancer. Western blot analysis and RT-PCR were employed to measure miR-133a and USP39 expression. To confirm whether miR-133a targeted USP39, we conducted a luciferase reporter assay. We utilized 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay to detect the effects of miR-133a on gastric cell proliferation. miR-133a was significantly downregulated in cancer tissues and cell lines (HGC-27 and MGC-803), while the expression level of USP39 was higher in tumor tissues than in paracancerous tissues. Upregulated expression of miR-133a and/or USP39 downregulation could inhibit cell proliferation in gastric cancer cells. Furthermore, USP39 was identified as a direct target of miR-133a and the inverse relationship between them was also observed. USP39 was a firsthand target of miR-133a and there was a negative correlation between them. In addition, a low expression of miR-133a or overexpression of USP39 predicted poor prognosis. In conclusion, miR-133a may be a novel therapeutic target of microRNA-mediated suppression of cell proliferation in CC, but the role of the miR-133a/USP39 axis in CC progression needs further study.

Citing Articles

LncRNA LINC00847 Accelerates Melanoma Progression by Regulating MiR-133a-3p/TGFBR1 Axis.

Jiang L, Shi X, Liu Y, Chen H Comb Chem High Throughput Screen. 2023; 27(8):1231-1241.

PMID: 37587809 DOI: 10.2174/1386207326666230816113411.

Research Progress for Targeting Deubiquitinases in Gastric Cancers.

An T, Lu Y, Gong Z, Wang Y, Su C, Tang G Cancers (Basel). 2022; 14(23).

PMID: 36497313 PMC: 9735992. DOI: 10.3390/cancers14235831.

miR-381 Inhibits Proliferation and Invasion of Non-Small-Cell Cancer Cells by Targeting USP39.

Cui F, Luo P, Wu R, Meng J Dis Markers. 2022; 2022:2195393.

PMID: 36046375 PMC: 9420621. DOI: 10.1155/2022/2195393.

FOXD3-induced miR-133a blocks progression and metastasis of colorectal cancer through regulating UBA2.

Cheng Y, Wang Y, Cheng Y, Yang Q, Zhang L, Li Z J Cancer. 2021; 12(20):6145-6154.

PMID: 34539887 PMC: 8425194. DOI: 10.7150/jca.60647.

Splicing factor USP39 promotes ovarian cancer malignancy through maintaining efficient splicing of oncogenic HMGA2.

Wang S, Wang Z, Li J, Qin J, Song J, Li Y Cell Death Dis. 2021; 12(4):294.

PMID: 33731694 PMC: 7969951. DOI: 10.1038/s41419-021-03581-3.

References

van Leuken R, Luna-Vargas M, Sixma T, Wolthuis R, Medema R . Usp39 is essential for mitotic spindle checkpoint integrity and controls mRNA-levels of aurora B. Cell Cycle. 2008; 7(17):2710-9. DOI: 10.4161/cc.7.17.6553. View

Lauressergues D, Couzigou J, San Clemente H, Martinez Y, Dunand C, Becard G . Primary transcripts of microRNAs encode regulatory peptides. Nature. 2015; 520(7545):90-3. DOI: 10.1038/nature14346. View

He B, Lin X, Tian F, Yu W, Qiao B . MiR-133a-3p Inhibits Oral Squamous Cell Carcinoma (OSCC) Proliferation and Invasion by Suppressing COL1A1. J Cell Biochem. 2017; 119(1):338-346. DOI: 10.1002/jcb.26182. View

Gong Y, Ren J, Liu K, Tang L . Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R. World J Gastroenterol. 2015; 21(10):2949-58. PMC: 4356914. DOI: 10.3748/wjg.v21.i10.2949. View

Lin Z, Xiong L, Lin Q . Ubiquitin-specific protease 39 is overexpressed in human lung cancer and promotes tumor cell proliferation in vitro. Mol Cell Biochem. 2016; 422(1-2):97-107. DOI: 10.1007/s11010-016-2809-8. View

Li W, Chen A, Xiong L, Chen T, Tao F, Lu Y . miR-133a acts as a tumor suppressor in colorectal cancer by targeting eIF4A1. Tumour Biol. 2017; 39(5):1010428317698389. DOI: 10.1177/1010428317698389. View

Voinnet O . Origin, biogenesis, and activity of plant microRNAs. Cell. 2009; 136(4):669-87. DOI: 10.1016/j.cell.2009.01.046. View

Yuan X, Sun X, Shi X, Wang H, Wu G, Jiang C . USP39 promotes colorectal cancer growth and metastasis through the Wnt/β-catenin pathway. Oncol Rep. 2017; 37(4):2398-2404. DOI: 10.3892/or.2017.5454. View

Wang L, Hsiao T, Hong T, Chen H, Kao S, Wang W . MicroRNA-133a suppresses multiple oncogenic membrane receptors and cell invasion in non-small cell lung carcinoma. PLoS One. 2014; 9(5):e96765. PMC: 4016005. DOI: 10.1371/journal.pone.0096765. View

10.

Christodoulatos G, Dalamaga M . Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis?. World J Clin Oncol. 2014; 5(2):71-81. PMC: 4014798. DOI: 10.5306/wjco.v5.i2.71. View

11.

Chen Y, Lin W, Zhu W, Lin J, Zhou Z, Huang C . Tumor MICA status predicts the efficacy of immunotherapy with cytokine-induced killer cells for patients with gastric cancer. Immunol Res. 2015; 64(1):251-9. DOI: 10.1007/s12026-015-8743-0. View

12.

Qiu T, Zhou X, Wang J, Du Y, Xu J, Huang Z . MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer. FEBS Lett. 2014; 588(7):1168-77. DOI: 10.1016/j.febslet.2014.02.054. View

13.

Wen D, Xu Z, Xia L, Liu X, Tu Y, Lei H . Important role of SUMOylation of Spliceosome factors in prostate cancer cells. J Proteome Res. 2014; 13(8):3571-82. DOI: 10.1021/pr4012848. View

14.

Choi Y, Noh S, Cheong J . Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine. Yonsei Med J. 2015; 56(5):1177-85. PMC: 4541645. DOI: 10.3349/ymj.2015.56.5.1177. View

15.

Lai C, Chen Z, Li R . MicroRNA-133a inhibits proliferation and invasion, and induces apoptosis in gastric carcinoma cells via targeting fascin actin-bundling protein 1. Mol Med Rep. 2015; 12(1):1473-8. DOI: 10.3892/mmr.2015.3545. View

16.

Guo J, Xia B, Meng F, Lou G . miR-133a suppresses ovarian cancer cell proliferation by directly targeting insulin-like growth factor 1 receptor. Tumour Biol. 2013; 35(2):1557-64. DOI: 10.1007/s13277-013-1215-z. View

17.

Cai J, Liu T, Huang P, Yan W, Guo C, Xiong L . USP39, a direct target of microRNA-133a, promotes progression of pancreatic cancer via the AKT pathway. Biochem Biophys Res Commun. 2017; 486(1):184-190. DOI: 10.1016/j.bbrc.2017.03.025. View

18.

Lygerou Z, Christophides G, Seraphin B . A novel genetic screen for snRNP assembly factors in yeast identifies a conserved protein, Sad1p, also required for pre-mRNA splicing. Mol Cell Biol. 1999; 19(3):2008-20. PMC: 83994. DOI: 10.1128/MCB.19.3.2008. View

19.

Clague M, Barsukov I, Coulson J, Liu H, Rigden D, Urbe S . Deubiquitylases from genes to organism. Physiol Rev. 2013; 93(3):1289-315. DOI: 10.1152/physrev.00002.2013. View

20.

Di Giacomo G, Koss M, Capellini T, Brendolan A, Popperl H, Selleri L . Spatio-temporal expression of Pbx3 during mouse organogenesis. Gene Expr Patterns. 2006; 6(7):747-57. DOI: 10.1016/j.modgep.2005.12.002. View